BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 23, 2020
View Archived Issues
Grant supports Epsilogen's development of cancer immunotherapeutic EPS-201
Read More
Targeting periphery could be viable approach in ALS
Read More
Ideaya and the Broad Institute partner to advance synthetic lethality programs
Read More
GlaxoSmithKline patents hSTING agonists
Read More
Kowa discloses CSF-1R inhibitors
Read More
TaiwanJ Pharmaceuticals presents new ENPP2 and HDAC dual inhibitors
Read More
Tera Stone synthesizes new compounds for cancer
Read More
Researchers discover new CNKs as antitumoral agents
Read More
FDA clears IND application for first-in-human study of ADI-001
Read More
Ionis initiates phase I/II study of ION-541 to treat broad ALS population
Read More
First-in-human data presented for JAK3 inhibitor TD-5202
Read More
Lp-PLA2 inhibition may limit cardiovascular damage from radiotherapy
Read More
FDA approves Veklury for patients with COVID-19 requiring hospitalization
Read More
Galera initiates phase I/II GRECO-1 study of GC-4711 plus SBRT in NSCLC
Read More
FDA issues complete response letter for Qtrypta
Read More
Preclinical data presented on intranasal oxytocin formulation for IBS
Read More
SGX-301 continues to demonstrate positive benefits in phase III FLASH study
Read More
ProTrans approved for clinical trials in patients with COVID-19
Read More
New phase II trial investigates PT-112 for metastatic CRPC
Read More
SARS-CoV-2 vaccine BBIBP-CorV safe and induces humoral responses in phase I/II study
Read More
bit.bio and London Institute for Mathematical Sciences partner on production of human cells
Read More
Adalimumab s.c. efficacious and safe option for children with ulcerative colitis
Read More
Altered cathepsin K secretion contributes to congenital heart defects in a model of mucolipidosis II
Read More
Phase III studies of a quadrivalent virus-like particle influenza vaccine manufactured in plants
Read More
AstraZeneca initiates phase III trial of monalizumab in recurrent or metastatic SCCHN
Read More
Tetra reports findings with ARDS-003 in induced pulmonary fibrosis model
Read More
